Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Nov-Dec;70(6):769-771.
doi: 10.1016/j.ihj.2018.12.001.

Legacy effect in medicine-the expanding horizon!

Gagandeep Singh Wander  1 , Manish Bansal  2
Affiliations
Editorial

Legacy effect in medicine-the expanding horizon!

Gagandeep Singh Wander et al. Indian Heart J. 2018 Nov-Dec.
No abstract available

PubMed Disclaimer

References

    1. Nathan D.M., Cleary P.A., Backlund J.Y. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–2653. - PMC - PubMed
    1. Group D.E.R., de Boer I.H., Sun W. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med. 2011;365:2366–2376. - PMC - PubMed
    1. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–1589. - PubMed
    1. Ford I., Murray H., McCowan C., Packard C.J. Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland coronary prevention study. Circulation. 2016;133:1073–1080. - PMC - PubMed
    1. Kostis W.J., Moreyra A.E., Cheng J.Q., Dobrzynski J.M., Kostis J.B. Continuation of mortality reduction after the end of randomized therapy in clinical trials of lipid-lowering therapy. J Clin Lipidol. 2011;5:97–104. - PubMed

Publication types

Substances